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(VI) ABSTRAK 
 
Atresia  esophageal ( EA) dan tracheoesophageal fistula (TEF) merupakan satu anomali 
kongenital yang berlaku kepada  bayi baru lahir dengan kejadian 1 dalam 2500 kelahiran di 
seluruh dunia. Terdapat 47 pesakit atresia esophageal yang dimasukkan ke HSB dari 
Januari 2000 ke Disember 2009, 26 (55%) lelaki dan 21 (45%) perempuan.  Agihan pesakit 
mengikut keturunan ialah seramai 34 Melayu (72%), 9 Cina (19%) dan 4 India (9%). 
Daripada 47 bayi yang mengidap TEF dan EA, 36% menghidap polyhdromnios dalam 
penilaian antenatal. Terdapat hanya 3 jenis EA/TEF yang kelihatan; Jenis A (9%), Jenis C 
(87%) dan Jenis E (4%). Julat berat bayi tersebut adalah dari 0.8kg hingga 4.0kg. Berat 
timbangan bayi paling kecil yang masih hidup ialah 1.1 kg dan terdapat perkaitan 
signifikan dengan hasil pembedahan (p<0.05). Kebanyakan bayi (20) dibedah dalam masa 
24 jam kelahiran. Tiada perkaitan signifikan di antara masa intervensi pembedahan dan 
hasil (p>0.05). 23 (49%) daripada mereka dilahirkan dengan kecacatan kongenital dan 
terdapat perkaitan signifikan dengan hasil pembedahan (p<0.05).  Berdasarkan 
roentgenogram dada, 20 (43%) daripada mereka menghidap pneumonia dan terdapat 
perkaitan signifikan dengan hasil (p<0.05).  Kadar kematian ialah 23% dan punca kematian 
ialah pneumonia yang teruk (36%), kegagalan ginjal yang teruk (18%), kecacatan jantung 
yang teruk (18%) dan kecacatan kongenital berbilang (28%).  Pengkelasan Bremen paling 
sesuai digunakan dalam menentukan prognosis bayi dengan TEF dan EA di Hospital 
Sultanah Bahiyah, Alor Setar. Sebagai kesimpulan, hasil EA dan TEF ditentukan  melalui 
berat lahir, kecacatan kongenital dan kehadiran pneumonia prapembedahan. 
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(VII) ABSTRACT 
 
Esophageal atresia (EA) and tracheoesophageal fistula (TEF) are one of the congenital 
anomaly occurring in the newborns with the incidence of 1 in 2500 births seen worldwide.  
There were 47 patients with esophageal atresia admitted to HSB from January 2000 to 
December 2009, out of which 26 (55%) were males and 21 (45%) females.  The 
distribution of patients by race were 34 Malays (72%), 9 Chinese (19%) and 4 Indians 
(9%).  Out of 47 babies with TEF and EA, 36% of them had polyhdromnios in the 
antenatal evaluation.  There were only 3 types of EA/TEF seen; Type A (9%), Type C 
(87%) and Type E (4%).  The birth weight of the babies range from 0.8 kg to 4.0 kg. The 
smallest surviving baby weighing 1.1 kg. There was a significant association with the 
outcome of the surgery (p< 0.05).  Most of the babies (20) were operated within 24 hours 
of presentation.  There were no significant association between time of surgical 
intervention and outcome (p>0.05).   23 (49%) of them were born with congenital 
malformation and there was a significant association with the outcome of the surgery 
(p<0.05).  Based on the chest roentgenogram, 20 (43%) of them had pneumonia with 
significant association with the outcome (p<0.05).  The mortality rate is 23% and the 
causes of death were severe pneumonia (36%), severe renal failure (18%), severe cardiac 
malformation (18%) and multiple congenital malformations (28%).  Bremen classification 
is most suitable in determining the prognosis of the babies with TEF and EA in Hospital 
Sultanah Bahiyah, Alor Star.  In conclusion, the outcome of EA and TEF is determined 
mainly by birth weight, congenital malformations and presence of preoperative pneumonia. 
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1.  INTRODUCTION 
Oesophageal atresia (EA) is a congenitally interrupted oesophagus.  Tracheoesophageal 
fistula (TEF) is a congenital or acquired communication between the trachea and 
oesophagus (Sharma et al. 2000).  EA and TEF are among the commonest congenital 
anomaly occurring in the newborns, with the incidence of 1 in 2500 births (Spitz L 2006).   
The incidence worldwide is reducing in trend for unknown reasons (Dave et al. 1999).   
 
Thomas Gibson first described EA and TEF in 1696.  Despite the identification and 
description, the first successful repair was only achieved two centuries later by Ladd and 
Lever in 1939 and 1940 (Myers 1997).  There are many surgical techniques used to repair 
TEF and EA, tested through time and adjusted to the anatomical variations the patient 
presents with (Krishinger et al 1999).  Post-operative care is as important as the surgery 
itself.  A good neonatal intensive care unit is a necessity to determine the success of the 
surgery (Sigmund et al 1989). 
 
The outcome depends on many factors, mainly the associated congenital anomalies with 
the TEF.  Waterston and Spitz have suggested different classifications that will determine 
the prognosis of the patient.  These classifications are based on the birth weight, timing of 
surgery and associated cardiac anomaly. There is no racial predilection for this condition.  
EA and TEF are usually diagnosed very early in life.  Currently, the survival rate is around 
80 - 90% (Deurloo et al 2000). 
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Complications that may arise can be early and late postoperative period.  These 
complications must be identified and treated accordingly. 
 
Hospital Sultanah Bahiyah offers the only paediatric surgical services in the northern 
region.  Almost all the babies diagnosed with EA/TEF in the northern region will be 
referred to us for further management.     
 
This study will provide a preliminary database for the cases performed in HSB in the past 
10 years. This study will also look into the outcome of babies with EA and TEF and to 
assess the associated risk factors influencing the outcome.  Identifying the relevant risk 
factors in the local centre will enable us to stratify the prognosis of the babies based on 
suitable prognostic criteria.   
 
It will also enable us to compare the standard of care in the management of EA/TEF 
between centres worldwide and assist in improving the shortcoming identified in the course 
of this study. 
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2.  LITERATURE REVIEW 
2.1 EPIDEMIOLOGY 
 
The incidence of EA and TEF is 1 in 2,500 (Spitz L 2006).  The incidence worldwide is in 
reducing trend for unknown reasons (Depaepe et al. 1993).  The highest incidence reported 
worldwide is in Finland with the incidence of 1 in 2,500 live births.  There is a slight male 
preponderance for the occurrence of this condition (Depaepe et al. 1993).  There is also a 
6% increased chance of having EA and TEF if it is a twin pregnancy.  It is also reported 
that more than 50% of babies with EA and TEF are associated with other congenital 
anomalies (Ishimaru et al. 1998).   
 
 
2.2 HISTORY 
Before the 17th
The initial part of the 20
 century, EA and TEF were poorly described and understood.  The babies 
with such conditions usually die.  William Durston first described the case of oesophageal 
atresia in one conjoined thoracopagus twin in 1670. In 1696, Thomas Gibson gave the first 
description of EA with a distal TEF. In 1862, Harald Hirschsprung, a famous Danish 
paediatrician, described 14 cases of oesophageal atresia. In 1898, Hoffman resorted to a 
gastrostomy after failing to anastomose the defect primarily (Myers 2006).  
th century was a great challenge for the surgeons to understand the 
condition and to formulate a solution.  It was until 1939 and 1940 when William E Ladd of 
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Boston and N. Logan Leven performed a staged procedure by ligating the fistula and 
placing a gastrostomy for feeding.  The reconstruction of the oesophagus was done later 
and the baby survived. However, a year later in 1941, Cameron Haight of Michigan 
successfully repaired oesophageal atresia in a single stage primary closure with an 
extrapleural approach in a 12-day-old baby (Spitz 2006). 
In the late part of 20th
 
 century, the survival of babies with EA and TEF improved 
tremendously.  This could be due to early diagnosis and referral, better neonatal care 
facilities, good neonatal transportation system, more experienced anesthetists with modern 
anesthesia, more intense postoperative care and last but not least, well trained surgeons 
(Spitz 2006).   
2.3 EMBRYOLOGY 
 
Oesophagus 
The initial stages of development are divided into the embryonic and fetal period.  
Beginning from fertilization up to the 9th week is the embryonic period.  Subsequently is 
called the fetal period.  In the first 2 weeks of development, the formation of the ectoderm 
and endoderm takes place.  From day 15 onwards, the mesoderm, which will give rise to 
the connective tissue, angioblast, smooth muscle and serosal layer of the gut will form.  
While the mesoderm proliferates, the human embryo elongates cranio caudally and folds 
laterally.  The yolk sac forms the dorsal part of the embryo and the embryo itself forms a 
‘body cylinder’ and is divided into the intraembryonic and the extraembryonic parts.  The 
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intraembryonic part gives rise to the digestive tract and the accessory glands.  The early 
digestive system divides into foregut, midgut and hindgut.  
 
The development of the gut takes place in four major axes (anterior-posterior, dorsal-
ventral, left-right and craniocaudal) and is influenced by epithelial mesenchymal 
interactions mediated by specific molecular pathways.  The oesophageal development takes 
places in the anterior-posterior axes and is mediated by growth factors such as Wnt5a 
(mesodermal protein), Six2/Sox2, Hoxa-2, 3 and 4 (endodermal proteins). 
 
In week 4 of the development, a small diverticulum develops on the ventral surface 
adjacent to the pharyngeal gut.  This diverticulum elongates and separates from the dorsally 
located foregut through the formation of the oesophageal tracheal septum and become the 
primitive respiratory tract.  The rest of the foregut develops rapidly along with the 
craniocaudal growth of the embryo.  By the 10th week, a single oesophageal lumen with a 
superficial layer of ciliated epithelial cells is formed.  Stratified squamous epithelium 
begins to replace the ciliated epithelial cells during the 4th
 
 month of development and this 
continues till birth.   
Trachea 
In the 4th week of the development, the lower respiratory tract develops from an outgrowth 
of the ventral wall of the foregut, also known as the respiratory diverticulum.  The 
epithelial lining of the larynx, trachea, bronchi and alveoli arise from the endodermal of the 
diverticulum.  The cartilaginous component of the trachea is derived from the splanchnic 
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mesoderm.  The elongation of the diverticulum caudally will separate it from the foregut by 
the oesophagotracheal septum.  The initial wide communication between the foregut and 
the tracheal will transform into a thin T-shaped slit and then disappear (Kuo and Urma 
2006).   
 
 
    
 
 
Figure 1:  The Development of the Respiratory Diverticulum (Adapted from GI Motility 
Online by Kuo B and Urma D, 2006).  
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2.4 ANATOMY 
 
Oesophagus 
 
Oesophagus is a flattened muscular tube with the length of 18 to 26 cm, begins from the 
lower border of the cricoid cartilage (at the level of C6 vertebrae and the upper sphincter) 
and ends at the cardiac orifice of the stomach at the level of T11 vertebrae.  The lumen of 
the oesophagus is naturally collapsed between swallows and distends to the size of 2cm 
anterior-posterior dimension and 3cm laterally.  The oesophagus can be described in three 
portions, the cervical oesophagus, the thoracic oesophagus and the abdominal oesophagus. 
 
The cervical oesophagus lies in front of the prevertebral fascia, posterior to the trachea and 
inclines slightly to the left of the midline when it enters the thoracic cavity.  The thoracic 
portion of the oesophagus returns to the midline at the level of T5 vertebrae and at T7, the 
oesophagus deviates to the left again and pass in front of the descending thoracic aorta, 
piercing the diaphragm 2.5cm to the left of the midline. Throughout the length of the 
thoracic oesophagus, the trachea is in direct anterior relation.  On the posterior plane, the 
oesophagus is crossed posteriorly by the hemiazygos, accessory hemiazygos and the right 
posterior intercostals arteries.  The abdominal oesophagus turns to the left and forward 
immediately after piercing the diaphragm and grooves the posterior portion of the left lobe 
of the liver. It enters the orifice of the cardia of the stomach. 
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The oesophagus wall is composed of four layers. They are the innermost mucosa, 
submucosa, muscularis propria and adventitia.  The oesophagus has no serosal layer. 
 
The blood supply of the oesophagus is based on the different portion of the oesophagus.  
The cervical oesophagus is supplied by the branches from the inferior thyroid artery.  The 
thoracic oesophagus is supplied by the paired branches of the thoracic aorta and the 
terminal branches of the bronchial arteries.  The abdominal oesophagus is supplied by the 
oesophageal branch of the left gastric artery and the branch from the left phrenic artery. 
 
The venous supply is also segmental.  The veins from the proximal and distal oesophagus 
drain into the azygos system whereas the mid oesophagus drains into the collaterals of the 
left gastric vein, a branch of the portal vein. 
 
The lymphatic from the proximal third of the oesophagus drains into the deep cervical 
lymph nodes and then into the thoracic duct.  The middle third of the oesophagus drain into 
the superior and mediastinal nodes.    The lymphatic flow of the distal third oesophagus 
drains following the left gastric artery into the gastric and celiac nodes. 
 
The oesophagus is innervated by the sympathetic and the parasympathetic nervous system, 
mainly by the vagal and the spinal nerves.   
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Trachea 
 
Similar to oesophagus, the trachea begins in the neck below the cricoid cartilage at the 
level of C6 vertebra, anterior to the oesophagus.  It enters the thoracic inlet at the midline 
and passes downwards and backwards posterior to the manubrium.  At the level of the T5 
vertebra, the trachea bifurcates into two main bronchi.  The entire length of the trachea is 
10cm long with the diameter of 2cm.   
 
The trachea receives the blood supply from the branches of the inferior thyroid artery and 
the bronchial arteries. The venous drainage is into the inferior thyroid vein. 
 
The lymphatic channels pass into the pre and paratracheal nodes and to the inferior deep 
cervical nodes.  
 
Tracheal nerve supply is derived from the vagus and the recurrent laryngeal nerve forming 
the parasympathetic portion.  The smooth muscle and the blood vessels is supplied by the 
sympathetic fibres from the sympathetic trunk (Sinnathamby 2006). 
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2.5 PATHOPHYSIOLOGY 
 
The trachea and oesophagus are very closely related from the early phase of embryonic 
life.  The development and separation of these structures are believed to be from apoptosis, 
which causes collapse and fusion of the lateral walls of the foregut.  Any point along the 
foregut that fails to achieve this will have a remnant septum that will form fistulous tract 
between the trachea and oesophagus (Dave et al. 1999).   
To understand the pathophysiology of EA, three separate studies were carried out.  They 
are the:  
1. the ontogeny of peptide innervation of the oesophagus; 
2. studies on the adriamycin rat model  
3. studies on the recently developed adriamycin mouse model  
Hitchcock et al was responsible to investigate on the ontogeny and distribution of 
neuropeptides that influences the growth of nerve cells density and myenteric fraction of 
the esophagus.  He discovered the density of these cells will peak at 16 to 20 weeks of 
gestation, which is around the time the fetal swallowing first occurs
Cheng et al
 in utero. 
 discovered that the immunoreactvity for S100 and galanin were significantly 
elevated in rats treated with adriamycin.  His postulation was that the abnormal distribution 
of the nerve tissue in the atretic esophagus contributes to the dysmotility even after the 
corrective surgery. 
11 
 
Subsequently, Ioannides et al 
 
created and adriamycin model of EA in the mouse because 
there were greater availability of molecular probes and genetic strains in the mouse than 
rats. He showed that in the absence of tracheoesophageal separation, the dorsal fistula 
retains its non respiratory commitment, that is, is of foregut origin and stains negative for 
Nkx2.1, a marker for respiratory elements. He also showed that sonic hedgehog gene (Shh) 
expression undergoes a reversal in the dorsoventral patterning during tracheoesophageal 
separation. This dorsoventral patterning is disturbed in the adriamycin mouse model of EA. 
However, despite all these studies, there are no babies with EA and TEF were documented 
to be exposed to adriamycin (Yagyu et al. 2000). 
EA could also be due to the dysfunction of the active cellular proliferation where the 
laryngotracheal tube grew faster than the oesophagus so that if separation of the 
oesophagus and trachea was slightly delayed, the faster growing trachea would separate the 
proximal and distal oesophagus. This will lead to a fistulous formation. 
 
Till today, the cause of EA or TEF is unknown.  There are no known human teratogens 
known to affect the foetus.  There are many postulations about the genetic predisposition of 
EA and TEF, but currently many authorities believe otherwise.  Having twin pregnancy has 
been associated with 6 times more likely to have EA (Dave et al. 1999).    
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In 1953, Gross and Boston described EA and TEF in six different types (Smith 2006).  
They are as follows:- 
 
Type A – Oesophageal atresia without fistula (pure oesophageal atresia), 10% 
Type B – Oesophageal atresia with proximal TEF, <1% 
Type C – Oesophageal atresia with distal TEF, 85% 
Type D – Oesophageal atresia with proximal and distal TEFs, <1% 
Type E – TEF without oesophageal atresia (the H-type fistula), 4% 
Type F – Congenital oesophageal stenosis, <1% 
 
 
 
Figure 2:  Anatomical variations of EA and TEF by Gross (Adapted from Oesophageal 
atresia, tracheo-oesophageal fistula, and the VACTERL association: review of genetics and 
epidemiology by Smith C.S
 
. from Journal of Medical Genetics 2006)  
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Foetus affected by EA will have difficulties in swallowing the amniotic fluid, especially if 
the fistula is absent.  Due to this incapability, the accumulated amniotic fluid will lead to 
polyhydromnios and subsequently into premature labour.  The foetus also absorbs some 
amount of nutritional values from the ingestion of amniotic fluid and this could be the 
cause for them being small for gestational age (Spitz 1996). 
 
Once born, the neonate will have copious amount of saliva drooling due to the inability to 
swallow.  If the neonate is allowed to suckle, the aspiration of the milk may lead to 
pneumonia and will severely impair the prognosis (Agarwal et al. 1996). The air can pass 
down the fistula when the baby cries, strains or need to be ventilated preoperatively.  This 
can cause severe distension of the gastric and lead to gastric perforation.   
 
Manometric studies in babies with EA have shown dysmotility in the entire length of the 
oesophagus.  This will cause poor propagating peristaltic waves and lead to dysphagia 
when the feeding starts.  Due to the lower oesophageal sphincter failure in cases of EA, the 
incidence of gastroesophageal reflux is high.  The reflux can lead to oesophageal stricture, 
aspiration pneumonia and tracheal collapse (Shekhawat et al. 2000). 
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2.6 CLASSIFICATION 
 
There are many classifications used to estimate the prognosis. Among the most frequently 
referred are the Waterston classification and Spitz classification.  
 
Waterston devised a classification system to assist in the management of EA and TEF in 
1962.  He classified them into three categories and is dependent on the birth weight, the 
pulmonary condition and congenital anomalies.  Those falling in category A will undergo 
immediate repair, category B will be delayed repair and category C will be staged repair.  
As the years go by, this classification was further simplified by Randolph in 1989.  He 
suggested a clinically helpful system that considers the physiological status to determine 
the surgical management.  Weight, pulmonary conditions and gestational age were not 
considered.  If the physiological parameters are promising, the baby is taken into surgery 
immediately.  Staged repairs are only used for those severely compromised babies, 
especially those with severe cardiac abnormalities (Deurloo et al. 2004). 
 
At a later period, in 1994, Spitz suggested a new classification system after reviewing 387 
babies.  He observed that the main prognostic factor in determining the outcome is actually 
the status of the cardiac disease.  He divided the babies into 3 groups, similar to Waterston 
but only based on the birth weight and the presence or absence of cardiac disease (Okamato 
et al. 2009).  Yagyu et al. suggested a modification to the Spitz classification, Bremen 
classification, in 2000 by adding on the preoperative pulmonary status, which better 
predicts the prognosis of the babies (Yagyu et al. 2000). 
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Table 1:  Prognostic classifications of EA and TEF (Spitz et al. 1993), (Deurloo et al. 2004) 
and (Eradi et al. 2003). 
Waterston Classification 
(1962) 
Spitz risk groups (1994) Bremen Classification 
(2000) 
A. Birth weight > 2500g 
   No pneumonia 
   No anomalies 
Group 1 
Birth weight >1500g 
No congenital heart disease 
Group 1 
Birth weight >1500g 
No congenital heart disease 
No pneumonia 
B. Birth weight 1800 – 2500g 
    Moderate pneumonia or 
anomalies. 
Group 2  
Birth weight < 1500g  
or congenital heart disease 
Group 2  
Birth weight < 1500g  
or congenital heart disease 
or pneumonia 
C.  Birth weight < 1800g 
       Or 
      Birth weight >1800g 
      with severe pneumonia  
       or severe anomalies. 
Group 3 
Birth weight < 1500g 
and congenital heart disease. 
Group 3 
Birth weight < 1500g 
and congenital heart disease 
or pneumonia 
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The survival rate based on the Waterston classification Group A, B and C are 99%, 93% 
and 71% respectively.  The Spitz Group 1, 2 and 3 have the survival rate of 97%, 59% and 
22% (Deurloo et al. 2000).  These classifications are only to assist physicians to compare 
results in an organized and meaningful way and not to make clinical decisions based 
entirely on it.  Each baby must be individualized in their treatment (Spitz et al. 1993). 
 
In developing countries, the survival rate depends not only on the mentioned factors, but 
also on the timing of the referral, hypothermia and high rate of pneumonia.  Many babies 
born in the outskirts will have delayed referral to the tertiary centre because of the lack in 
experience in making the diagnosis upon delivery (Agarwala et al. 1996). 
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2.7  PRESENTATION 
 
Mothers delivering babies with EA can be complicated with polyhdromnios during their 
pregnancy.  This happens in 33% of the mothers carrying babies with EA and TEF.  It 
happens in 100% of cases with only atresia without fistula (Spitz et al. 1993).  
Polyhdromnios will lead to premature delivery and worsen the prognosis (Saxena 2008).  
Antenatal suspicion will ensure the mother delivers in a tertiary centre where there is a 
paediatric surgical service and neonatal medical services. 
 
Babies born with EA and TEF will have drooling salivation.  Noting this, a nasogastric 
tube should be inserted and if the tube coils in the cervical oesophagus (around 10cm from 
the upper gum), then it is highly suggestive of EA.  Risk of aspiration pneumonia is 
increased due to this.  It is important to ensure the saliva is continuously cleared from the 
oral cavity by the nursing staff or by using the Replogle suction tube on continuous low 
pressure suction in the upper pouch (Dave et al. 1999).  Besides salivation, babies fed after 
delivery will develop respiratory distress and aspiration pneumonia.  A chest and 
abdominal x-ray is performed to look for the coiling of the nasogastric tube and also to 
identify the presence of bowel shadows.  Absence of bowel shadow may suggest there is no 
fistula (Type A or B) and vice versa. In Type A or B, a preoperative bronchoscopy may 
assist in determining the presence of proximal fistula. Oesophagogram is not necessary in 
the diagnosis (Dave et al. 1999).   
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Figure 3:  Plain roentgenogram of chest showing coiled nasogastric tube and gasless 
abdomen (Adapted from Esophageal Atresia with Distal Tracheoesophageal 
Fistula with Gasless Abdomen: A Diagnostic Dilemma by Hassan Z, 
Upadhyaya V and Gangopadhyay A from The Internet Journal of Pediatrics
 
 
2009) 
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Figure 4:  Double lumen Replogle suction tube (Adapted from Covidien online brochure 
http://www.covidien.com/criticalcare/pageBuilder.aspx?contentID=150958&we
bPageID=0&topicID=146881&breadcrumbs=0:121623,144286:0) 
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2.8 ASSOCIATED ANOMALIES 
 
Anomalies associated with EA and TEF are mainly linked to the VACTERL complex.  
VACTERL refers to the anomalies of the vertebrae or spinal columns (V), atretic gut (A), 
cardiac anomalies (C), tracheoesophageal defect (TE), renal agenesis (R) and limb defects 
(L).  If 3 or more of this defects are detected, VACTERL association is present and this 
occurs in 25% of babies with EA and TEF (Smith 2006). The most common anomalies 
recorded in previous studies were cardiac defects, followed by vertebrae, renal, atretic gut 
and limbs.  Rate of mortality among babies of EA and TEF with cardiac anomalies are 
significantly higher than those without (Encinas et al. 2006). 
 
It is believed there is a keystone changes in the early embryogenesis that leads to the wide 
spectrum of anomalies in a very consistent manner.  The Shh gene is known to play an 
important role in EA.  The Shh gene encodes an intracellular signalling molecule and its 
deficient will produce VACTERL anomalies in mice.  Some studies have also shown that 
overactivity of the Shh gene can lead to branching of the fistulous tract from the lung and 
lead to TEF.  It is also shown that Shh gene plays an important role in the development of 
the hindgut.  The defect in this gene will lead to hindgut anomalies like imperforate anus 
that is commonly seen in cases of EA (Smith 2006).   
 
Another gene, the DLL gene was recently discovered having missense mutation in a patient 
with VACTERL complex.  Although the relationship between the DLL and Shh gene is 
unclear, it is unlikely the act in a separate pathway in causing the VACTERL complex. 
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Vertebral anomaly occurs in about 24% of babies with EA (Keckler et al. 2007).  Vertebral 
defect is usually associated with other lesions of the axial spine including the ribs. The 
most common combination of anomalies consisted of rib anomalies, vertebral body defects, 
and tethered cord. Vertebral anomalies did not contribute to mortality (Keckler et al. 2007).   
In a review of 40 patients, an increased mortality was seen in patients with an extra 
thoracic vertebral segment. This observation was associated with an increased anastomotic 
leak rate, theoretically due to greater tension as others have found a wider gap due to a 
higher proximal pouch in patients with an associated anomaly of the axial skeleton 
(Upadhyaya et al. 2007). 
 
Anorectal malformation was noted to occur with the incidence of 14.3% (Keckler et al. 
2007).  The defects associated with VACTERL malformations are higher in this group of 
patients.  Detecting anorectal malformation will indicate to the physician to look hard for 
other associated anomalies.  The following probability for the displaying one of the other 
VACTERL defects are vertebral(58.3%), duodenal atresia (16.7%), cardiac (58.3%), 
internal urinary (58.3%), limb (33.3%), and chromosomal (8.3%) (Sinha et al. 2008). 
 
Cardiac anomalies are detected in 32.1% of the patients with EA. The most common 
component of heart disease was a ventricular septal defect occurring in 22.3%, which was a 
component of multiple heart lesions in most patients as an isolated ventricular septal defect 
occurred in only 7.1% (Encinas et al. 2006). Notably, cyanotic heart disease was found to 
be uncommon with 4.5% patients presenting with such a defect, and all were tetralogy of 
Fallot. Of the population of patients that has a tetralogy of Fallot, a worse outcome has 
been recognized for those who have extracardiac manifestations (Encinas et al. 2006). 
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Encinas et al. reported a 50% mortality for patients that have a tetralogy of Fallot and 
another manifestation of the VACTERL complex. 
 
 
Urinary malformation occurs in about 17.0% cases (Keckler et al. 2007).  Vesico-ureteral 
reflux was the most common anomaly.  Other types of urogenital anomaly are renal 
agenesis, horseshoe kidney, polycystic kidney and cloacal anomaly (Uehling et al. 1983).  
In EA patients with urinary anomaly, other VACTERL defects that present concomitantly 
are vertebral (47.4%), anorectal (36.8%), cardiac (73.7%), limb (26.3%) (Keckler et al. 
2007).  
 
Skeletal malformation occurs in about 16.1% of cases.  Peripheral skeletal anomalies were 
less common at 8.9% (Okada et al. 1997). Digital anomalies were the most common within 
this class, followed by an absent radius (Deurloo et al. 2004). 
 
Other anomalies that overlap with VACTERL association are CHARGE syndrome, 
Trisomy 13, 21, 18 and Fanconi syndrome. 
 
CHARGE syndrome is an autosomal dominant genetic disorder typically caused by 
mutations in the chromodomain helicase DNA-binding protein-7 (CHD7) gene (Vissers 
L.E et al. 2004). The acronym "CHARGE" denotes the nonrandom association of 
coloboma, heart anomalies, choanal atresia, retardation of growth and development, and 
genital and ear anomalies, which are frequently present in various combinations and to 
varying degrees in individuals with CHARGE syndrome.  No single feature is universally 
present or sufficient for the clinical diagnosis of CHARGE syndrome, and numerous 
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guidelines have been published to aid in establishing a likely clinical diagnosis (Pagon R.A 
et al. 1981). 
Blake et al suggested that a typical clinical diagnosis of CHARGE syndrome requires the 
presence of at least 4 major features or 3 major features plus at least 3 minor features.  
Major features include ocular coloboma or microphthalmia, choanal atresia or stenosis, 
cranial nerve abnormalities, and characteristic auditory and/or auricular anomalies. Minor 
features include distinctive facial dysmorphology, facial clefting, tracheoesophageal fistula, 
congenital heart defects, genitourinary anomalies, developmental delay, and short stature 
(Blake et al. 1998).  Other frequently associated abnormal findings include characteristic 
hand dysmorphology, hypotonia, deafness, and dysphagia (Verloes A 2005).  
A developmental defect involving the midline structures of the body occurs, specifically 
affecting the craniofacial structures.  This defect is attributed to arrest in embryologic 
differentiation in the second month of gestation, when the affected organs are in the 
formative stages (choanae at 35-38 days' gestation, eye at 5 weeks' gestation, cardiac 
septum at 32-38 days' gestation, cochlea at 36 days' gestation, external ear at 6 weeks' 
gestation) (Jones K.L 1997).  The prechordal mesoderm is necessary for the development 
of the mid face and exerts an inductive role on the subsequent development of the 
prosencephalon, the forepart of the brain.  
The mechanisms suggested are: 
(1)  Deficiency in migration of cervical neural crest cells into the derivatives of the 
pharyngeal pouches and arches.  
(2)  Deficiency of mesoderm formation 
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(3)  Defective interaction between neural crest cells and mesoderm, resulting in defects 
of blastogenesis and hence the typical phenotype.  
 
CHARGE syndrome and EA/TEF are related via the overlap in the VACTERL association.  
Both these syndromes can be confused on presentation as they exhibit common features 
such as tracheoesophageal fistula, cardiac malformations and genitourinary anomaly.  
Although the management of TEF do not differ, it is important to identify the right 
syndrome the baby is affected with to identify all the other associated defects and treat 
them accordingly. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
